Corundum Open Innovation
Corundum Innovation is a venture capital firm established in 2014, with headquarters in Herzelia, Tel Aviv, and an additional presence in Tokyo, Japan. The firm specializes in investments in information and communication technology (ICT) and life sciences sectors, primarily targeting Israeli high-tech companies. Corundum Innovation offers portfolio companies access to a robust high-tech ecosystem, providing valuable market insights, go-to-market strategies, and introductions to top talent and strategic business partners. By fostering hands-on business development, the firm aims to enhance the growth potential of both its investors and portfolio companies.
Theranica
Series C in 2022
Theranica is a medical device company that specializes in developing wearable solutions for various medical conditions, particularly focusing on migraine treatment. The company utilizes neuromodulation therapy combined with advanced wireless technology to create noninvasive 'smart' patches. These patches are controlled via a smartphone app, allowing for personalized treatment that is both portable and cost-effective. Each patch features a proprietary chip that delivers electrical pulses to modulate sensory nerves beneath the skin, providing temporary or long-term relief from pain. Theranica's innovative approach aims to empower patients in managing their neurological pain effectively and affordably.
Theranica
Series B in 2019
Theranica is a medical device company that specializes in developing wearable solutions for various medical conditions, particularly focusing on migraine treatment. The company utilizes neuromodulation therapy combined with advanced wireless technology to create noninvasive 'smart' patches. These patches are controlled via a smartphone app, allowing for personalized treatment that is both portable and cost-effective. Each patch features a proprietary chip that delivers electrical pulses to modulate sensory nerves beneath the skin, providing temporary or long-term relief from pain. Theranica's innovative approach aims to empower patients in managing their neurological pain effectively and affordably.
CathWorks
Series B in 2017
CathWorks Ltd. is a medical technology company that specializes in enhancing percutaneous coronary intervention (PCI) therapy decisions through its advanced computational science platform. Founded in 2013 and headquartered in Kfar-Saba, Israel, with an additional office in the United States, the company has developed the CathWorks FFRangio, a non-invasive device that provides objective, multi-vessel physiologic measurements. This tool transforms coronary angiography from a subjective visual assessment into an objective decision-making framework based on fractional flow reserve (FFR) metrics. By utilizing sophisticated algorithms to process visual information, CathWorks aims to improve the efficiency of cath lab operations and support healthcare providers in making data-driven clinical decisions.
Theranica
Series A in 2017
Theranica is a medical device company that specializes in developing wearable solutions for various medical conditions, particularly focusing on migraine treatment. The company utilizes neuromodulation therapy combined with advanced wireless technology to create noninvasive 'smart' patches. These patches are controlled via a smartphone app, allowing for personalized treatment that is both portable and cost-effective. Each patch features a proprietary chip that delivers electrical pulses to modulate sensory nerves beneath the skin, providing temporary or long-term relief from pain. Theranica's innovative approach aims to empower patients in managing their neurological pain effectively and affordably.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.